2Cheung A K.Samak M J,Yan G,et al.Aherosclerotic cardiovasvular disease risks in chronichemodialysis patients[J].Kidney bat,2000,(58):353-362.
3Causes of death:USRDS.United States Renal Data System[J].Am J Kidney Dis,1997,(30,2Suppl 1):S107-S117.
4Parfrey P S,Harnnet J D,Foley R N,et al.Impact of renal transplantation on uremic cardio-myopathy[J].Transplantation,1995,60(9):908.
5Delanghe J R,De Mol A M,De Buyzere M L,et al.Mass concentration and activity concentration of creatine kinase isoenzyme MB compared in serum after acute myocardial infarction[J].Clin Chem,1990,36(1):149-153.
6Wu A H,Lu Q A,Todd J,et al.Short-and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay:implications for clinical practice[J].Clinical Chemistry,2009,55(1):52-58.
7Bottomley P A,Wu K C,Gerstenblith G,et al.Reduced myocardial creatine kinase flux in human myocardial infarction:an in vivo phosphorus magnetic resonance spectroscopy study[J].Circulation,2009,119(14):1 918-1 924.
8Perepech N B,Nedoshivin A O,Nesterova I V.Neoton and thrombolytic therapy of myocardial infarction[J].Ter Arkh,2001,73(9):50-55.
9Lorentzon M,R(a)munddal T,Bollano E,et al.In vivo effects of myocardial creatine depletion on left ventricular function,morphology,and energy metabolism-consequences in acute myocardial infarction[J].J Card Fail,2007,13(3):230-237.
